Clinical trial
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating…
NCT00045305 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00045305 |
|---|---|
| Title | Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes |
| Official title | A Phase II Study of Reduced Intensity Allogeneic Bone Marrow Transplant for the Treatment of Myelodysplastic Syndromes |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Cyclosporine, Methotrexate, Photopheresis, Mycofenolate mofetil, Pentostatin, allogeneic bone marrow, peripheral blood stem cell, Total body irradiation |
| Enrollment | 17 |
| Start date | Oct 24, 2006 |
| Primary completion | Feb 1, 2014 |
| Completion | Sep 1, 2014 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 28, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: